fosinopril has been researched along with Erythrocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lal, SM; Trivedi, H | 1 |
| Burris, L; Croizat, H; Devarajan, P; Glicklich, D; Greenstein, S; Schechner, R; Tellis, V; Urban, A | 1 |
1 trial(s) available for fosinopril and Erythrocytosis
| Article | Year |
|---|---|
A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Azathioprine; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Creatinine; Cross-Over Studies; Cyclosporine; Fosinopril; Hematocrit; Hemoglobins; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Polycythemia; Postoperative Complications; Potassium; Prednisone; Prospective Studies; Theophylline; Treatment Outcome; Vasodilator Agents | 2003 |
1 other study(ies) available for fosinopril and Erythrocytosis
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antigens, CD34; Apoptosis; Erythroid Precursor Cells; Female; Fosinopril; Hematocrit; Humans; Insulin-Like Growth Factor I; Kidney Transplantation; Lisinopril; Male; Polycythemia; Reference Values | 2001 |